Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia

CDC42 controls intestinal epithelial (IEC) stem cell (IESC) division. How aberrant CDC42 initiates intestinal inflammation or neoplasia is unclear. We utilized models of inflammatory bowel diseases (IBD), colorectal cancer, aging, and IESC injury to determine the loss of intestinal Cdc42 upon inflam...

Full description

Bibliographic Details
Main Authors: Dongsheng Zhang, Wenjuan Tang, Haitao Niu, William Tse, Hai-Bin Ruan, Helmut Dolznig, Thomas Knösel, Friedrich Karl-Heinz, Madeleine Themanns, Jiang Wang, Mingquan Song, Lee Denson, Lukas Kenner, Richard Moriggl, Yi Zheng, Xiaonan Han
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-01-01
Series:Genes and Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304222003300
_version_ 1827267106188558336
author Dongsheng Zhang
Wenjuan Tang
Haitao Niu
William Tse
Hai-Bin Ruan
Helmut Dolznig
Thomas Knösel
Friedrich Karl-Heinz
Madeleine Themanns
Jiang Wang
Mingquan Song
Lee Denson
Lukas Kenner
Richard Moriggl
Yi Zheng
Xiaonan Han
author_facet Dongsheng Zhang
Wenjuan Tang
Haitao Niu
William Tse
Hai-Bin Ruan
Helmut Dolznig
Thomas Knösel
Friedrich Karl-Heinz
Madeleine Themanns
Jiang Wang
Mingquan Song
Lee Denson
Lukas Kenner
Richard Moriggl
Yi Zheng
Xiaonan Han
author_sort Dongsheng Zhang
collection DOAJ
description CDC42 controls intestinal epithelial (IEC) stem cell (IESC) division. How aberrant CDC42 initiates intestinal inflammation or neoplasia is unclear. We utilized models of inflammatory bowel diseases (IBD), colorectal cancer, aging, and IESC injury to determine the loss of intestinal Cdc42 upon inflammation and neoplasia. Intestinal specimens were collected to determine the levels of CDC42 in IBD or colorectal cancer. Cdc42 floxed mice were crossed with Villin-Cre, Villin-CreERT2 and/or Lgr5-eGFP-IRES-CreERT2, or Bmi1-CreERT2 mice to generate Cdc42 deficient mice. Irradiation, colitis, aging, and intestinal organoid were used to evaluate CDC42 upon mucosal inflammation, IESC/progenitor regenerative capacity, and IEC repair. Our studies revealed that increased CDC42 in colorectal cancer correlated with lower survival; in contrast, lower levels of CDC42 were found in the inflamed IBD colon. Colonic Cdc42 depletion significantly reduced Lgr5+ IESCs, increased progenitors' hyperplasia, and induced mucosal inflammation, which led to crypt dysplasia. Colonic Cdc42 depletion markedly enhanced irradiation- or chemical-induced colitis. Depletion or inhibition of Cdc42 reduced colonic Lgr5+ IESC regeneration. In conclusion, depletion of Cdc42 reduces the IESC regeneration and IEC repair, leading to prolonged mucosal inflammation. Constitutive monogenic loss of Cdc42 induces mucosal inflammation, which could result in intestinal neoplasia in the context of aging.
first_indexed 2024-03-12T15:20:07Z
format Article
id doaj.art-b0fc0e6ade90487d8ef2c302ccd35c04
institution Directory Open Access Journal
issn 2352-3042
language English
last_indexed 2025-03-22T04:28:28Z
publishDate 2024-01-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Genes and Diseases
spelling doaj.art-b0fc0e6ade90487d8ef2c302ccd35c042024-04-28T04:50:56ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422024-01-01111413429Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasiaDongsheng Zhang0Wenjuan Tang1Haitao Niu2William Tse3Hai-Bin Ruan4Helmut Dolznig5Thomas Knösel6Friedrich Karl-Heinz7Madeleine Themanns8Jiang Wang9Mingquan Song10Lee Denson11Lukas Kenner12Richard Moriggl13Yi Zheng14Xiaonan Han15Division of Hematology and Oncology, Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center (MHMC), Case Western Reserve University (CWRU), School of Medicine, Cleveland, OH 44109, USA; Cancer Genomics and Epigenomics Program, Case Comprehensive Cancer Center, Case Western Reserve University (CWRU), Cleveland, OH 44106, USA; Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH 45229, USADivision of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH 45229, USA; Children's Hospital of Fudan University, Shanghai 201102, ChinaSchool of Medicine, Jinan University, Guangzhou, Guangdong 510632, China; Laboratory Animal Science (ILAS), Chinese Academy of Medical Science (CAMS) and Peking Union Medical College (PUMC), Beijing 100006, ChinaDivision of Hematology and Oncology, Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center (MHMC), Case Western Reserve University (CWRU), School of Medicine, Cleveland, OH 44109, USA; Cancer Genomics and Epigenomics Program, Case Comprehensive Cancer Center, Case Western Reserve University (CWRU), Cleveland, OH 44106, USADepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MI 55455, USAInstitute of Medical Genetics, Medical University of Vienna, Vienna 1040, AustriaInstitute of Pathology, Ludwig-Maximilians-University Munich, Munich 80539, GermanyInstitute of Biochemistry II, University Hospital Jena, Jena 07743, GermanyLaboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna 1210, AustriaDepartment of Pathology, University of Cincinnati, Cincinnati, OH 45221, USADepartment of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266005, ChinaDivision of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH 45229, USADepartment of Pathology, Medical University of Vienna, Vienna 1040, AustriaLudwig Boltzmann Institute for Cancer Research, Vienna 1090, Austria; Medical University of Vienna, Vienna 1040, Austria; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna 1210, AustriaDivision of Experimental Hematology, CCHMC, Cincinnati, OH 45229, USADivision of Hematology and Oncology, Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center (MHMC), Case Western Reserve University (CWRU), School of Medicine, Cleveland, OH 44109, USA; Cancer Genomics and Epigenomics Program, Case Comprehensive Cancer Center, Case Western Reserve University (CWRU), Cleveland, OH 44106, USA; Corresponding author. 2500 Metrohealth Dr, Rammelkamp 461, Cleveland, OH 44109, USA.CDC42 controls intestinal epithelial (IEC) stem cell (IESC) division. How aberrant CDC42 initiates intestinal inflammation or neoplasia is unclear. We utilized models of inflammatory bowel diseases (IBD), colorectal cancer, aging, and IESC injury to determine the loss of intestinal Cdc42 upon inflammation and neoplasia. Intestinal specimens were collected to determine the levels of CDC42 in IBD or colorectal cancer. Cdc42 floxed mice were crossed with Villin-Cre, Villin-CreERT2 and/or Lgr5-eGFP-IRES-CreERT2, or Bmi1-CreERT2 mice to generate Cdc42 deficient mice. Irradiation, colitis, aging, and intestinal organoid were used to evaluate CDC42 upon mucosal inflammation, IESC/progenitor regenerative capacity, and IEC repair. Our studies revealed that increased CDC42 in colorectal cancer correlated with lower survival; in contrast, lower levels of CDC42 were found in the inflamed IBD colon. Colonic Cdc42 depletion significantly reduced Lgr5+ IESCs, increased progenitors' hyperplasia, and induced mucosal inflammation, which led to crypt dysplasia. Colonic Cdc42 depletion markedly enhanced irradiation- or chemical-induced colitis. Depletion or inhibition of Cdc42 reduced colonic Lgr5+ IESC regeneration. In conclusion, depletion of Cdc42 reduces the IESC regeneration and IEC repair, leading to prolonged mucosal inflammation. Constitutive monogenic loss of Cdc42 induces mucosal inflammation, which could result in intestinal neoplasia in the context of aging.http://www.sciencedirect.com/science/article/pii/S2352304222003300Cell division cycle 42 (CDC42)ColitisColorectal cancer (CRC)Inflammatory bowel diseases (IBD)Intestinal epithelial cell (IEC)Intestinal epithelial stem cell (IESC)
spellingShingle Dongsheng Zhang
Wenjuan Tang
Haitao Niu
William Tse
Hai-Bin Ruan
Helmut Dolznig
Thomas Knösel
Friedrich Karl-Heinz
Madeleine Themanns
Jiang Wang
Mingquan Song
Lee Denson
Lukas Kenner
Richard Moriggl
Yi Zheng
Xiaonan Han
Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
Genes and Diseases
Cell division cycle 42 (CDC42)
Colitis
Colorectal cancer (CRC)
Inflammatory bowel diseases (IBD)
Intestinal epithelial cell (IEC)
Intestinal epithelial stem cell (IESC)
title Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
title_full Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
title_fullStr Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
title_full_unstemmed Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
title_short Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia
title_sort monogenic deficiency in murine intestinal cdc42 leads to mucosal inflammation that induces crypt dysplasia
topic Cell division cycle 42 (CDC42)
Colitis
Colorectal cancer (CRC)
Inflammatory bowel diseases (IBD)
Intestinal epithelial cell (IEC)
Intestinal epithelial stem cell (IESC)
url http://www.sciencedirect.com/science/article/pii/S2352304222003300
work_keys_str_mv AT dongshengzhang monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT wenjuantang monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT haitaoniu monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT williamtse monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT haibinruan monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT helmutdolznig monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT thomasknosel monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT friedrichkarlheinz monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT madeleinethemanns monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT jiangwang monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT mingquansong monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT leedenson monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT lukaskenner monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT richardmoriggl monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT yizheng monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia
AT xiaonanhan monogenicdeficiencyinmurineintestinalcdc42leadstomucosalinflammationthatinducescryptdysplasia